Physician profile
James M Graham
NPI 1356346167
$1,379.86
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $552 · 2020: $179 · 2021: $182 · 2022: $165 · 2023: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $249.64 | 2019-2021 | |
| Therapeuticsmd, INC. | $210.94 | 2019-2022 | |
| Coopersurgical, INC. | $168.22 | 2019-2023 | Paragard T 380a |
| Pacira Pharmaceuticals Incorporated | $108.36 | 2021 | |
| Pfizer INC. | $83.87 | 2019-2022 | |
| Intuitive Surgical, INC. | $81.07 | 2023 | |
| Hologic Sales and Service, LLC | $64.23 | 2019 | |
| Exeltis, USA INC. | $62.84 | 2023 | Slynd |
| Mayne Pharma Commercial LLC | $59.56 | 2022-2023 | |
| Ge Healthcare | $55.32 | 2023 | |
| Stryker Corporation | $44.05 | 2022 | |
| Duchesnay USA Incorporated | $40.88 | 2019 | |
| Lupin INC. | $40.03 | 2019 | |
| Allergan, INC. | $37.69 | 2019 | |
| Astellas Pharma US INC | $26.34 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $21.59 | 2023 | |
| Ascend Therapeutics US, LLC | $13.54 | 2022 | |
| Merck Sharp & Dohme LLC | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.